Latest funding round for NHMRC and MRFF announced
Congratulations to MDHS staff and partners for recent successes in NHMRC and MRFF funding rounds.
Dr Charbel Darido Peter MacCallum Cancer Centre
Evaluating clinically relevant biomarkers to improve early detection and treatment of head and neck cancer.
Professor Sarah-Jane Dawson Peter MacCallum Cancer Centre
Novel predictive disease modelling using liquid biopsies to improve outcomes in melanoma
Dr Piers Blombery Peter MacCallum Cancer Centre
Diagnosis, discovery and novel phenotype characterisation using multimodal genomics in patients with inherited bone marrow failure and related disorders
Professor Ian Campbell Peter MacCallum Cancer Centre
Genetic mosaicism as a stable and robust blood DNA biomarker for precision risk assessment for cancer
Associate Professor Michael Hildebrand Medicine, Austin Health
Precision Diagnosis for the Remaining 50% of Unsolved Developmental and Epileptic Encephalopathies
Dr Kate Hayward Department of Physiotherapy
Reaching for your words: A Phase IIa umbrella trial of integrated UPper limb & Language Impairment and Functional Training (UPLIFT) after stroke.
Professor Dominique Cadilhac Florey Institute
Improving life after stroke with tailored support: Innovation in use of national registry data
Professor Stephen Kent Department of Microbiology and Immunology and Peter Doherty Institute
Chimeric next generation COVID vaccines
Professor Joseph Torresi Department of Microbiology and Immunology and Peter Doherty Institute
AdaptiVax-CoV: A Novel Self-adjuvanting SARS-CoV2 VLP Vaccine to Produce Humoral and T cell responses to S, E and M proteins
Associate Professor Noleen Bennett Department of Nursing
Evaluation of an aged care infection surveillance system
Professor Kwang Lim Medicine, Royal Melbourne Hospital
Preventing infection in residential care
Professor Mark Dawson Peter MacCallum Cancer Centre Studying the origins, maintenance and resistance mechanisms of poor risk paediatric leukaemia at single cell resolution to develop novel therapeutic approaches
Associate Professor Joanne Said Department of Obstetrics and Gynaecology
The C*STEROID Trial: An international, randomised placebo-controlled trial to determine the effect of antenatal corticosteroids on newborn health when given prior to planned caesarean section birth from 35+0 to 39+6 weeks of pregnancy.
Professor Kim Bennell Department of Physiotherapy
HipHealth-an exercise and weight loss telehealth program to improve outcomes for Australians with hip osteoarthritis
Professor David Ritchie Medicine, Royal Melbourne Hospital
Repurposing BCL-2 inhibitors for immune manipulation to improve outcomes in allogeneic stem cell transplantation
Dr Christopher Bye Florey Institute
iPSC clinical trials - population wide screening of patient iPSC’s to reassess high value drug targets for motor neuron disease
Dr Lincon Stamp Florey Institute and Department of Anatomy and Physiology
Stem cell therapies for digestive disease
Dr Fana Alemseged Medicine, Royal Melbourne Hospital
POST ETERNAL Extending the time window for Tenecteplase by Effective RecanalizatioN of bAsiLar artery thrombus in patients with POSTerior circulation stroke
Associate Professor David Gyorki Peter MacCallum Cancer Centre
A Randomised phase III study of neoadjuvant chemotherapy followed by surgery versus surgery alone for patients with high-risk retroperitoneal sarcoma (STRASS 2)
Professor Tony Penington Peter MacCallum Cancer Centre
Targeted therapies for vascular malformations
Professor Niall Corcoran Medicine, Royal Melbourne Hospital
Platform to Enhance Prostate Cancer Shared care Integration (PEPSI)
Professor Elizabeth Vincan Department of Infectious Diseases, VIDRL
Professor Alice Pebay Department of Surgery, Department of Anatomy and Physiology
Novel SMART AAV vectors for gene therapy for Friedreich’s Ataxia (led by University of Wollongong)
Dr Alex Harris Medicine, St Vincent's Hospital
Insights into CDKL5 neuronal regulation: pathways to improving neurological outcomes for CDKL5 Deficiency Disorder